Annual Total Assets
$1.73 B
-$108.24 M-5.88%
31 December 2023
Summary:
Halozyme Therapeutics annual total assets is currently $1.73 billion, with the most recent change of -$108.24 million (-5.88%) on 31 December 2023. During the last 3 years, it has risen by +$1.15 billion (+198.88%). HALO annual total assets is now -5.88% below its all-time high of $1.84 billion, reached on 31 December 2022.HALO Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$2.12 B
+$148.58 M+7.54%
30 September 2024
Summary:
Halozyme Therapeutics quarterly total assets is currently $2.12 billion, with the most recent change of +$148.58 million (+7.54%) on 30 September 2024. Over the past year, it has increased by +$225.37 million (+11.91%). HALO quarterly total assets is now at all-time high.HALO Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HALO Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.9% | +11.9% |
| 3 y3 years | +198.9% | +78.7% |
| 5 y5 years | +293.7% | +471.9% |
HALO Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -5.9% | +198.9% | at high | +91.8% |
| 5 y | 5 years | -5.9% | +293.7% | at high | +471.9% |
| alltime | all time | -5.9% | >+9999.0% | at high | >+9999.0% |
Halozyme Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.12 B(+7.5%) |
| June 2024 | - | $1.97 B(+6.9%) |
| Mar 2024 | - | $1.84 B(+6.2%) |
| Dec 2023 | $1.73 B(-5.9%) | $1.73 B(-8.4%) |
| Sept 2023 | - | $1.89 B(+4.5%) |
| June 2023 | - | $1.81 B(+6.5%) |
| Mar 2023 | - | $1.70 B(-7.7%) |
| Dec 2022 | $1.84 B(+66.7%) | $1.84 B(-1.2%) |
| Sept 2022 | - | $1.86 B(+4.7%) |
| June 2022 | - | $1.78 B(+53.3%) |
| Mar 2022 | - | $1.16 B(+5.2%) |
| Dec 2021 | $1.10 B(+90.4%) | $1.10 B(-6.8%) |
| Sept 2021 | - | $1.19 B(+15.6%) |
| June 2021 | - | $1.03 B(+6.1%) |
| Mar 2021 | - | $966.58 M(+66.7%) |
| Dec 2020 | $579.92 M(+2.5%) | $579.92 M(+10.7%) |
| Sept 2020 | - | $524.03 M(-0.6%) |
| June 2020 | - | $527.00 M(+7.0%) |
| Mar 2020 | - | $492.35 M(-13.0%) |
| Dec 2019 | $565.87 M(+28.5%) | $565.87 M(+52.8%) |
| Sept 2019 | - | $370.36 M(-11.4%) |
| June 2019 | - | $417.83 M(-2.6%) |
| Mar 2019 | - | $429.11 M(-2.5%) |
| Dec 2018 | $440.25 M(-15.3%) | $440.25 M(-1.0%) |
| Sept 2018 | - | $444.51 M(-6.4%) |
| June 2018 | - | $474.75 M(-4.2%) |
| Mar 2018 | - | $495.47 M(-4.7%) |
| Dec 2017 | $519.95 M(+98.8%) | $519.95 M(+45.6%) |
| Sept 2017 | - | $357.15 M(+3.6%) |
| June 2017 | - | $344.79 M(+52.0%) |
| Mar 2017 | - | $226.77 M(-13.3%) |
| Dec 2016 | $261.51 M(+43.9%) | $261.51 M(-7.4%) |
| Sept 2016 | - | $282.50 M(-4.6%) |
| June 2016 | - | $296.13 M(-4.2%) |
| Mar 2016 | - | $309.10 M(+70.0%) |
| Dec 2015 | $181.79 M(+9.5%) | $181.79 M(+14.5%) |
| Sept 2015 | - | $158.73 M(-8.8%) |
| June 2015 | - | $174.05 M(+9.4%) |
| Mar 2015 | - | $159.13 M(-4.1%) |
| Dec 2014 | $165.98 M(+63.1%) | $165.98 M(+0.8%) |
| Sept 2014 | - | $164.63 M(-9.6%) |
| June 2014 | - | $182.05 M(-7.9%) |
| Mar 2014 | - | $197.69 M(+94.2%) |
| Dec 2013 | $101.79 M | $101.79 M(-7.6%) |
| Sept 2013 | - | $110.15 M(+2.6%) |
| June 2013 | - | $107.39 M(-8.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $116.87 M(-13.3%) |
| Dec 2012 | $134.73 M(+104.9%) | $134.73 M(+24.8%) |
| Sept 2012 | - | $107.98 M(-11.3%) |
| June 2012 | - | $121.75 M(-9.6%) |
| Mar 2012 | - | $134.72 M(+104.9%) |
| Dec 2011 | $65.76 M(-28.0%) | $65.76 M(-16.0%) |
| Sept 2011 | - | $78.24 M(-12.6%) |
| June 2011 | - | $89.51 M(+10.6%) |
| Mar 2011 | - | $80.93 M(-11.4%) |
| Dec 2010 | $91.35 M(+18.4%) | $91.35 M(-9.0%) |
| Sept 2010 | - | $100.39 M(+95.0%) |
| June 2010 | - | $51.49 M(-21.0%) |
| Mar 2010 | - | $65.16 M(-15.5%) |
| Dec 2009 | $77.15 M(+0.8%) | $77.15 M(-10.4%) |
| Sept 2009 | - | $86.11 M(-10.6%) |
| June 2009 | - | $96.30 M(+39.7%) |
| Mar 2009 | - | $68.93 M(-10.0%) |
| Dec 2008 | $76.56 M(-26.0%) | $76.56 M(-5.2%) |
| Sept 2008 | - | $80.75 M(-8.8%) |
| June 2008 | - | $88.56 M(-10.4%) |
| Mar 2008 | - | $98.87 M(-4.4%) |
| Dec 2007 | $103.46 M(+124.5%) | $103.46 M(-5.9%) |
| Sept 2007 | - | $109.99 M(+5.6%) |
| June 2007 | - | $104.13 M(+41.0%) |
| Mar 2007 | - | $73.87 M(+60.3%) |
| Dec 2006 | $46.09 M(+124.7%) | $46.09 M(+158.8%) |
| Sept 2006 | - | $17.81 M(+5.8%) |
| June 2006 | - | $16.84 M(-11.2%) |
| Mar 2006 | - | $18.97 M(-7.5%) |
| Dec 2005 | $20.51 M(+25.0%) | $20.51 M(+177.7%) |
| Sept 2005 | - | $7.39 M(-32.5%) |
| June 2005 | - | $10.94 M(-21.2%) |
| Mar 2005 | - | $13.88 M(-15.4%) |
| Dec 2004 | $16.40 M(+2434.6%) | $16.40 M(+333.4%) |
| Sept 2004 | - | $3.79 M(-39.0%) |
| June 2004 | - | $6.21 M(-19.7%) |
| Mar 2004 | - | $7.73 M(+1094.8%) |
| Dec 2003 | $647.20 K(+180.7%) | $647.20 K(+850.4%) |
| Sept 2003 | - | $68.10 K(-11.6%) |
| June 2003 | - | $77.00 K(-16.3%) |
| Mar 2003 | - | $92.00 K(-60.1%) |
| Dec 2002 | $230.60 K(+783.5%) | $230.60 K(+68.6%) |
| Sept 2002 | - | $136.80 K(-7.3%) |
| June 2002 | - | $147.50 K(+289.2%) |
| Mar 2002 | - | $37.90 K |
| Dec 2001 | $26.10 K | - |
FAQ
- What is Halozyme Therapeutics annual total assets?
- What is the all time high annual total assets for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual total assets year-on-year change?
- What is Halozyme Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly total assets year-on-year change?
What is Halozyme Therapeutics annual total assets?
The current annual total assets of HALO is $1.73 B
What is the all time high annual total assets for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual total assets is $1.84 B
What is Halozyme Therapeutics annual total assets year-on-year change?
Over the past year, HALO annual total assets has changed by -$108.24 M (-5.88%)
What is Halozyme Therapeutics quarterly total assets?
The current quarterly total assets of HALO is $2.12 B
What is the all time high quarterly total assets for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly total assets is $2.12 B
What is Halozyme Therapeutics quarterly total assets year-on-year change?
Over the past year, HALO quarterly total assets has changed by +$225.37 M (+11.91%)